“It’s not often that a single product catapults a whole industry upward,” writes business newspaper Handelsblatt, but then again the product offered by German coronavirus vaccine developer BioNTech is no ordinary one.
In the global race to deal with Covid-19, Germany’s extensive network of pharmaceutical companies are involved in major international collaborations and are benefiting from generous government support. German pharma is driving digitalization forward.
Global exports may be down because of the various restrictions associated with the Covid-19 pandemic, but 2020 is shaping up to be an excellent year for German pharmaceutical companies.
With the entire world looking for responses to the coronavirus pandemic, Germany’s pharmaceutical companies are attracting considerable attention. We asked Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies, for an update on the progress in developing anti-corona medications.
Over the Counter (OTC): People in Germany have been self-medicating more and more in recent years. Sales of prescription-free drugs are increasing at pharmacies and through online mail order services. Why?
The Association of Researching Pharmaceutical Companies (vfa) says 36 newly approved medications have been introduced to the German market in 2022. That continues the strong innovation trend from 2021, when 46 new medicines were introduced in the calendar year, vfa added.
Germany’s chemical industry is large and prosperous but it’s also one of the biggest emitters of greenhouse gases. That needs to change if Germany is to meet its 2045 climate goals – and green hydrogen is at the heart of the solution.
We talk to Germany Trade & Invest’s India director Seema Bhardwaj and director general of the Indo-German Chamber of Commerce Stefan Halusa about relations between the two economic powerhouses.
Over the past decade, healthtech startups in the Bavarian capital have taken in just under EUR 968 million in financing – that’s according to information compiled by the website Munich Startup in its Data & Insights Dashboard.
Germany’s digital quantum leap is a priority for the new coalition government – and international companies are invited to help jump-start the future.
If you are not happy with the results below please do another search
